Gene Query: RAPGEFL1

Dataset Description Geneva Score
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 47.91
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 45.88
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 45.88
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 42.31
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 42.31
Silencing p300 in MCF7 cells to study expression and alternative splicing 38.21
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 34.65
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 33.12
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 33.12
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 30.48
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 30.28
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 30.28
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 27.91
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 26.93
NR2F2 study 26.93
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 26.72
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 26.72
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 26.69
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 26.69
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 25.36
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 25.25
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 25.13
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 25.13
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 24.93
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 23.7
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 22.73
RNA-seq differential expression studies: more sequence, or more replication? 22.61
circRNA profile in hypopharyngeal cancer 22.11
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 21.61
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 20.93
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 20.44
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 19.86
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 19.77
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 19.64
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 19.55
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 19.55
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 18.11
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 18.05
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 18.02
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 17.9
The transcriptome effect of overexpressing EZH2 in MCF7 17.71
Transcriptomic and gene ontology profiling of the human corneal cell types 16.75
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 16.16
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 15.89
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 15.85
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 15.78
H1609088 Human RNA-Sequencing 15.48
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 15.07
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 14.73
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 14.73
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 14.71
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 14.38
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 14.25
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 14.18
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 13.88
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 13.68
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 13.51
Regulation of hypoxia-inducible factor activity by ZMYND8 13.2
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 13.01
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 13.01
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 12.94
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 12.91
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 12.67
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 12.34
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 12.34
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 12.33
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 12.1
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 11.97
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 11.97
Gene expression profile in breast cancer cell lines using RNA sequencing 11.83
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 11.59
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 11.59
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 11.49
Patient-derived luminal breast cancer xenografts with progestins 11.49
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 11.46
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 11.35
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 11.16
The Genomic Landscape of Atypical Fibroxanthoma 10.61
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 10.38
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 10.24
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 10.08
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 10.05
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 10.05
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 9.94
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 9.94
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 9.71
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 9.41
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 9.41
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 9.17
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 9.17
RNA-Seq analysis of breast cancer cells after shikonin treatment 9.08
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 9.04
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 8.96
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 8.91
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 8.64
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 8.6
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 8.47
RNAseq of cell lines with knocked in ESR1 mutations 8.42
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 8.31
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 8.31
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 8.3
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 8.0
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 7.95
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 7.95
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 7.76
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 7.55
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 7.53
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 7.38
Epigenome regulation during epidermal lineage commitment [RNA-seq] 7.29
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 7.29
mRNA sequencing of oropharyngeal cancer cell lines 7.18
RNA-seq analysis of breast cancer 7.12
RNA-seq analysis and shRNA screen of breast cancer 7.12
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 7.04
Gene expression analysis of breast cancer cell-lines 6.99
Gene expression and genome-wide location analysis of breast cancer cell-lines 6.99
BAF controls genome accessibility 6.65
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 6.62
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 6.51
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 6.51
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 6.51
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 6.47
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 6.45
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 6.45
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 6.44
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 6.36
Rorc disruption in human FG pancreatic cancer cells 6.29
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 6.24
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 6.21
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 6.19
The Glioma-Infiltrating T Cell Receptor Repertoire 6.14
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 6.11
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 6.09
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 6.02
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 6.01
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 5.99
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 5.9
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 5.9
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 5.87
Electronic cigarettes 5.83
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 5.69
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 5.65
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 5.65
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 5.62
Splicing and epigenetic factors jointly regulate epidermal differentiation 5.62
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 5.6
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 5.57
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 5.56
RNA sequencing of human mammary epithelial cells 5.5
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 5.47
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 5.47
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 5.47
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 5.44
RNA-sequencing in immortalized human mammary epithelial cells 5.39
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 5.39
Conservative alteration of chromosomal expression pattern across human solid tumor types 5.3
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 5.2
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 5.11
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 5.1
RNA-sequencing 5.07
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 5.05
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 4.99
Overexpression of NFIB and YBX1 in MCF-7 cells 4.99
circRNA-sequencing 4.98
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 4.97
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 4.86
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 4.83
Fusion discovery in breast cancer cell line 4.77
RNA-sequencing of formalin fixed human primary melanoma tissue 4.75
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 4.75
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 4.74
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 4.73
Repurposing of promoters and enhancers during mammalian evolution 4.66
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 4.65
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 4.62
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 4.52
Expression profiling of MCF-7 cells with treatment of TCDD 4.42
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 4.42
Integrin signaling regulates YAP/TAZ to control skin homeostasis 4.4
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 4.4
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 4.4
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 4.38
A transcriptome dataset revealing the molecular features of breast cancer stem cells 4.31
ENCODE Cold Spring Harbor Labs Long RNA-seq 4.27
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.19
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.19
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 4.11
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 4.1
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 4.1
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 4.1
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 4.04
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 4.04
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 4.03
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 4.02
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 3.99
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 3.98
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 3.95
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 3.95
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 3.94
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 3.94
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 3.93
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 3.93
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 3.9
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 3.86
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 3.84
The gene expression profiles of gallbladder cancer 3.82
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 3.8
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 3.79
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 3.78
Downregulation of LATS kinases alters p53 to promote cell migration 3.74
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 3.71
Effect of from Human Umbilical Vein Endothelial Cells 3.71
SETBP1-WT and SETBP1-G870S epigenetic landscapes 3.68
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 3.68
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 3.61
Gene expression alterations of pancreatic intraepithlial neoplasia 3.57
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 3.55
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 3.54
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 3.53
A transcriptome-wide divergence in protein translation scales with LIN28B expression 3.5
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 3.5
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 3.49
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 3.47
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 3.44
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 3.44
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 3.4
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 3.38
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 3.34
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 3.32
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 3.32
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 3.31
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 3.3
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 3.3
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  3.3
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 3.29
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 3.29
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 3.27
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 3.26
PTHrP overexpression in MCF7 cells 3.24
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 3.22
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 3.11
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 3.09
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 3.03
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 3.0
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 3.0
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 2.98
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 2.97
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 2.94
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 2.94
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 2.92
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 2.92
RNA seq analysis of human Fetal and adult derived Enterospheres 2.88
RNAseq of IL-36 stimulated primary human keratinocytes 2.81
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 2.8
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 2.77
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 2.74
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 2.73
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 2.66
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 2.65
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 2.65
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 2.61
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 2.61
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 2.55
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 2.5
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 2.49
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 2.48
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 2.48
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 2.46
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 2.46
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 2.45
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 2.42
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 2.37
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 2.37
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 2.37
MRTF activates TEAD-YAP target gene expression 2.34
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 2.34
snRNAs as regulators of alternative splicing 2.29
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 2.28
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 2.28
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 2.23
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 2.19
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 2.19
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 2.19
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 2.19
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 2.18
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 2.17
Active translatome profiling with RiboLace in MCF7 cells 2.16
MCF-7 as a model for functional analysis of breast cancer risk variants 2.16
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 2.14
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 2.12
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 2.11
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 2.09
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 2.09
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 2.06
Identifying the molecular mode of action of itraconazole in colorectal cancer 2.05
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 2.05
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 2.02
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 2.01
Interaction between mitoNEET and NAF-1 in cancer cells 1.97
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 1.96
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 1.94
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 1.94
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 1.94
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 1.93
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 1.93
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 1.92
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 1.92
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 1.9
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 1.9
SLIGRL-induced gene expression changes in NHEK cells 1.88
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 1.86
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 1.84
RNA-Seq analysis of human colorectal cancer with liver metastasis 1.84
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 1.84
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.83
Gene expression analysis upon mtDNA depletion 1.83
circNFIB suppresses lymphatic metastasis of pancreatic cancer 1.82
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  1.81
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 1.81
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 1.8
Interphase condensins regulate ligand-depedent enhancer activation 1.8
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 1.79
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 1.78
AR-independent prostate cancer is sustained through FGF signaling 1.77
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 1.74
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 1.74
Identification of global regulators of T-helper cell lineage specification 1.68
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 1.68
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 1.68
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 1.67
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 1.67
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 1.67
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 1.67
RNA-seq of MCF10A cells and CAF 1.65
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 1.63
Recovery and analysis of nascent RNA 1.63
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.58
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 1.56
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 1.54
ML29755 RNA-seq data 1.53
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 1.52
Epigenome regulation during epidermal lineage commitment 1.5
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.5
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 1.5
p63 controls the enhancer landscape during keratinocyte differentiation 1.49
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 1.49
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 1.48
Transcriptome analysis of human lung epithelial cells 1.48
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 1.48
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.46
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 1.45
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 1.39
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 1.39
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 1.38
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 1.37
The circadian transcriptional landscape in primary human mammary epithelial cells 1.36
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 1.35
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 1.35
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 1.34
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 1.34
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 1.33
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 1.33
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 1.32
BASP1 modifies the Tamoxifen response 1.32
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 1.32
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 1.31
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 1.3
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.3
Persistence of stem cell metabolism in cancers as a failure of differentiation 1.27
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 1.25
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 1.24
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 1.24
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.23
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 1.23
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 1.23
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.23
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.22
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 1.17
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 1.17
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 1.17
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 1.17
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 1.16
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 1.16
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 1.12
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 1.11
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 1.07
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 1.05
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 1.05
The effect of Abl kinases on non-small cell carcinoma global transcriptome 1.04
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 1.04
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 1.04
RNAseq analysis of ruxolitinib treated breast cancers 1.0
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.97
The MEF2B Regulatory Network - RNA-seq data 0.95
The MEF2B Regulatory Network 0.95
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 0.93
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 0.9
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 0.9
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 0.88
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.88
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.88
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 0.88
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 0.87
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.85
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 0.82
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 0.82
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 0.81
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 0.8
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.79
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.79
RNA-Seq of the corpus callosum from 12 individuals 0.73
The age and genomic integrity of neurons after cortical stroke in humans 0.71
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 0.71
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 0.71
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.7
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.7
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 0.69
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 0.69
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.69
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.69
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.69
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 0.67
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.67
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.67
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 0.66
Differential Protein Occupancy Profiling of the mRNA Transcriptome 0.66
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.65
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.65
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 0.65
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.64
Fbxo32 mediated gene expression program underlies EMT and metastasis 0.63
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.63
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 0.62
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 0.61
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.61
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.59
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.59
RNA Sequencing of three pairs of gastric cancer 0.58
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 0.57
Human embryonic stem cells in E8 and AKIT culture medium 0.56
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.56
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.56
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.55
The expression profiles of GBC liver metastasis 0.53
CUREfast: Accelerating research with families 0.53
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.5
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.49
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 0.48
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 0.47
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 0.47
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.47
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 0.47
Transcriptomic analysis of frontal fibrosing alopecia 0.46
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.45
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 0.44
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.43
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.43
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 0.42
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 0.42
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 0.42
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.41
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.38
RNA-seq of SCLC PDX models treated with EP 0.37
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.36
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.36
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 0.35
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.34
Effect of nuclear IL-33 on gene expression 0.32
Multiple sclerosis and EAE 0.31
Human optic chiasm from healthy controls and multiple sclerosis patients 0.31
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.28
RNAseq in Alzheimer's Disease patients 0.28
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.28
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.27
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.27
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 0.27
The interplay between SOX4 and SMAD3 in the context of breast cancer 0.27
Preclinical model of obesity and ER-positive breast cancer 0.26
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.25
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.25
RNA-Seq in neutrophils from Antiphospholipid Syndrome 0.25
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 0.25
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.24
Transcriptomic analysis of human macrophages in 3D 0.23
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.22
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 0.21
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 0.21
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 0.17
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.17
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.16
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.16
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.16
Gene expression analysis of human adenomas. 0.14
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.1
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 0.08
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 0.07
RNA sequencing of human pancreatic cancer cell lines 0.06
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.06
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.03
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation